Clinical Trials Directory

Trials / Conditions / Myelogenous Leukemia

Myelogenous Leukemia

7 registered clinical trials studyying Myelogenous Leukemia — 1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingRadioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
NCT07157514
Actinium PharmaceuticalsPhase 2 / Phase 3
UnknownIs There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance
NCT04965649
Centre Hospitalier Universitaire de Nīmes—
TerminatedStudy of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute
NCT02203773
AbbViePhase 1
TerminatedNilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase
NCT00519090
Novartis PharmaceuticalsPhase 3
CompletedStudy of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
NCT00133367
Massachusetts General HospitalPhase 2
TerminatedA Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752
NCT00100152
Merck Sharp & Dohme LLCPhase 1
CompletedSirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation
NCT00144703
Dana-Farber Cancer InstitutePhase 2